DHG enter Spanish market with acquisition of medical device supplier MediCauce
Medical device manufacturer DHG has completed the acquisition of MediCauce SL, one of Spain’s leading suppliers of solutions for safe moving and handling, pressure ulcer prevention, hygiene and rehabilitation.
Founded in 2015 by CEO Felipe Cabanas, and headquartered in Toledo, MediCauce quickly established itself as a premier provider of medical device solutions within the Spanish market, backed by its team’s service and knowledge within the market.
Since its foundation, MediCauce and DHG have partnered closely, enabling customers of MediCauce to benefit from the high-regarded SystemRoMedic range of safe moving and handling solutions.
With the completion of the acquisition finalised at the end of December 2023, MediCauce continues to operate as it did prior to the acquisition, led by Felipe Cabanas and his experienced team.
DHG are commited to investing in the continued growth of MediCauce within Spain, seeking to grow the team directly whilst at the same time enabling it to benefit from the wider expertise that DHG brings as a pan-European designer and manufacturer of innovative solutions for individuals impacted by reduced movement.
The acquisition of MediCauce provides DHG with a direct presence within the Spanish market. It also provides MediCauce’s existing customer-base with an enhanced portfolio of solutions, including the Raizer falls management chair.
Falls continue to be a major public health concern within Spain, with recent studies demonstrating that 32 per cent of those aged between 65-80 have suffered at least one fall within the last 12 months.
Ensuring that these individuals are safely risen from a fall position within a short period of time is essential in preventing longer-term morbidities.
Graham Ewart, CEO of DHG, said: “Felipe and his team have done an excellent job in building such a well-regarded business within Spain, thanks to their unwavering commitment to their customer-base and their unrivalled knowledge.
“The trust that MediCauce have built with their customers is invaluable to DHG as we enter the Spanish market, and we are actively investing within the team to enable MediCauce to continue to provide its customer with the unique level of support and service they have come to expert as the business transitions into its next phase of growth.”
Felipe Cabanas, CEO of MediCauce, said: “Through the years we have established a very close working partnership with DHG to the benefit of our customers.
“MediCauce fits seamlessly into DHG and provides us with the support we need to continue to best serve our market, whether that be through enhanced service provision or innovative new solutions.
“We will continue to work tirelessly to provide customers of MediCauce, both existing and new, with an exceptional level of service.
DHG’s growth is backed by ArchiMed, an independent investment firm specialised in the healthcare industries, who encourage strategic growth through dedicated resources and with significant capital investment.
Both ArchiMed and DHG seek new ways to support efforts to move health forward by delivering innovating and leading solutions for individuals whose lives are impacted by reduced movement.
Founded in 2009, DHG currently holds 15 per cent market share across Europe for its category, with a direct presence in five European countries, and further distribution in 35 countries across Asia, North America and Australasia.
